Dr. Kulreet Chaudhary’s combined expertise in both modern neurology and the ancient science of health known as Ayurveda has uniquely positioned her as an expert able to pull from the broadest possible base to treat her clients. She is passionate about raising awareness for the need of a paradigm shift in contemporary medicine that focuses on patient empowerment and a health-based (rather than disease-based) medical system. Dr. Chaudhary is a regular guest on the Dr. Oz show, where her teachings about Ayurvedic medicine have been applauded by a national audience.
Dr. Chaudhary was the Director of Wellspring Health in Scripps Memorial Hospital for ten years, and remains a pioneer in the field of Integrative Medicine. Dr. Chaudhary has successfully developed a powerful system to manage chronic neurological disorders such as multiple sclerosis, Parkinson’s disease and migraine headaches, by incorporating fundamental changes in diet, behavior, and stress, in addition to the standard allopathic approach to these issues. This program has been so successful that many patients now use it not just for neurological issues but also for a wider range of health concerns, including weight issues and chronic disease.
Dr. Chaudhary now serves as the Chief Medical Officer for New Practices, Inc. where she is changing allopathic medical practices into healing centers using compassion-based health coaching, meditation, and integrative medicine to combat chronic diseases such as Alzheimer’s disease, diabetes, obesity, coronary heart disease, addictions, and more. She also oversees ongoing research in management and reversal of chronic disease through lifestyle intervention. Dr. Chaudhary is creating a new model for healthcare that is based on teaching patients the principles of health and personal transformation in an environment of compassion, empowering them to live in a way that promotes maximum healing and vitality.
Dr. Kulreet Chaudhary is also a neuroscientist. She has participated in over twenty clinical research studies in the areas of multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, ALS, and diabetic peripheral neuropathy. Her research includes groundbreaking work in stem cell therapies for diabetic peripheral neuropathy and drug development for the treatment of ALS.